Regulon

Regulon: R-2862

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
19-0.58230810Pr-153Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
672 ENSG00000012048 BRCA1 P38398
1663 ENSG00000013573 DDX11 Q96FC9
29894 ENSG00000071894 CPSF1 Q10570
7514 ENSG00000082898 XPO1 O14980
4174 ENSG00000100297 MCM5 P33992
1869 ENSG00000101412 E2F1 Q01094
3609 ENSG00000129351 ILF3 A0A024R7C7
1786 ENSG00000130816 DNMT1 P26358
23225 ENSG00000132182 NUP210 Q8TEM1
4678 ENSG00000132780 NASP E9PAU3
4288 ENSG00000148773 MKI67 P46013
6749 ENSG00000149136 SSRP1 Q08945
64783 ENSG00000162775 RBM15 Q96T37
7753 ENSG00000166261 ZNF202 O95125
10036 ENSG00000167670 CHAF1A Q13111
5426 ENSG00000177084 POLE Q07864
8241 ENSG00000182872 RBM10 A0A0S2Z4X1
9735 ENSG00000184445 KNTC1 P50748
7516 ENSG00000196584 XRCC2 O43543

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DECITABINEDNMT1Small moleculeINHIBITORDNA (cytosine-5)-methyltransferase 3A inhibitor40
TROXACITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor20
CLOFARABINEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor40
EDIFOLIGIDE SODIUME2F1OligonucleotideINHIBITORE2F inhibitor30
CYTARABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor41
GEMCITABINE HYDROCHLORIDERRM1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
SELINEXORXPO1Small moleculeINHIBITORExportin-1 inhibitor42
GEMCITABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor40
AZACITIDINEDNMT1Small moleculeINHIBITORDNA (cytosine-5)-methyltransferase 1 inhibitor40
ASPACYTARABINEPOLA1Small moleculeINHIBITORDNA polymerase (alpha/delta/epsilon) inhibitor20
FLUDARABINE PHOSPHATEPOLA1Small moleculeINHIBITORRibonucleoside-diphosphate reductase RR1 inhibitor41

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2862

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs